Fusion of the dendritic cell-targeting chemokine MIP3α to melanoma antigen Gp100 in a therapeutic DNA vaccine significantly enhances immunogenicity and survival in a mouse melanoma model
Crossref DOI link: https://doi.org/10.1186/s40425-016-0189-y
Published Online: 2016-12-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gordy, James T.
Luo, Kun
Zhang, Hong
Biragyn, Arya
Markham, Richard B.